8-K Announcements
6Apr 29, 2026·SEC
Apr 13, 2026·SEC
Mar 23, 2026·SEC
Everest Re Group, Ltd. (EG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Everest Re Group, Ltd. (EG) stock price & volume — 10-year historical chart
Everest Re Group, Ltd. (EG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Everest Re Group, Ltd. (EG) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $16.08vs $13.97+15.1% | $4.1Bvs $4.2B-2.4% |
| Q1 2026 | Feb 4, 2026 | $13.26vs $13.36-0.7% | $4.4Bvs $4.5B-1.5% |
| Q4 2025 | Oct 27, 2025 | $7.54vs $14.63-48.5% | $4.3Bvs $4.4B-4.4% |
| Q3 2025 | Jul 30, 2025 | $17.36vs $15.14+14.7% | $4.4Bvs $3.9B+13.3% |
Everest Re Group, Ltd. (EG) competitors in Property and casualty reinsurers — business model, growth, and fundamentals comparison
Everest Re Group, Ltd. (EG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Everest Re Group, Ltd. (EG) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.62B | 7.36B | 8.23B | 9.6B | 11.33B | 11.98B | 14.46B | 17.08B | 17.32B | 17.15B |
| Revenue Growth % | 14.29% | 11.16% | 11.81% | 16.61% | 18.02% | 5.8% | 20.68% | 18.06% | 1.42% | -0.49% |
| Medical Costs & Claims | 5.83B | 7.17B | 6.63B | 8.42B | 9.6B | 10.63B | 11.38B | 14.61B | 13.76B | 12.26B |
| Medical Cost Ratio % | 87.98% | 97.4% | 80.51% | 87.77% | 84.75% | 88.68% | 78.67% | 85.53% | 79.48% | 71.52% |
| Gross Profit | 795.75M▲ 0% | 191.06M▼ 76.0% | 1.6B▲ 739.8% | 1.17B▼ 26.8% | 1.73B▲ 47.2% | 1.36B▼ 21.5% | 3.08B▲ 127.3% | 2.47B▼ 19.9% | 3.55B▲ 43.8% | 4.88B▲ 0% |
| Gross Margin % | 12.02% | 2.6% | 19.49% | 12.23% | 15.25% | 11.32% | 21.33% | 14.47% | 20.52% | 28.48% |
| Gross Profit Growth % | -45.72% | -75.99% | 739.8% | -26.83% | 47.19% | -21.47% | 127.34% | -19.9% | 43.82% | - |
| Operating Expenses | 376.34M | 433.24M | 505.56M | 588M | 184M | 769M | 931M | 976M | 1.6B | 2.44B |
| OpEx / Revenue % | 5.68% | 5.89% | 6.14% | 6.13% | 1.62% | 6.42% | 6.44% | 5.72% | 9.24% | 14.24% |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | 93.67% | 103.29% | 86.65% | 93.89% | 86.37% | 95.09% | 85.11% | 91.25% | 88.72% | 85.77% |
| Operating Income | 419.41M▲ 0% | -242.18M▼ 157.7% | 1.1B▲ 553.8% | 586M▼ 46.7% | 1.54B▲ 163.5% | 588M▼ 61.9% | 2.15B▲ 266.3% | 1.5B▼ 30.6% | 1.95B▲ 30.7% | 2.44B▲ 0% |
| Operating Margin % | 6.33% | -3.29% | 13.35% | 6.11% | 13.63% | 4.91% | 14.89% | 8.75% | 11.28% | 14.23% |
| Operating Income Growth % | -61.87% | -157.74% | 553.79% | -46.68% | 163.48% | -61.92% | 266.33% | -30.59% | 30.7% | - |
| EBITDA | 451.01M | -211.15M | 1.13B | 621M | 1.62B | 689M | 2.29B | 1.64B | 2.07B | 2.52B |
| EBITDA Margin % | 6.81% | -2.87% | 13.74% | 6.47% | 14.27% | 5.75% | 15.82% | 9.62% | 11.94% | 14.68% |
| Interest Expense | 31.6M | 31.03M | 31.69M | 36M | 70M | 101M | 134M | 149M | 139M | 137M |
| Non-Operating Income | -31.6M | -31.03M | -31.69M | -35M | -72M | -101M | -134M | -147M | -114M | -77M |
| Pretax Income | 419.41M▲ 0% | -242.18M▼ 157.7% | 1.1B▲ 553.8% | 585M▼ 46.8% | 1.55B▲ 164.3% | 588M▼ 62.0% | 2.15B▲ 266.3% | 1.49B▼ 30.7% | 1.93B▲ 29.2% | 2.42B▲ 0% |
| Pretax Margin % | 6.33% | -3.29% | 13.35% | 6.1% | 13.65% | 4.91% | 14.89% | 8.74% | 11.14% | 14.09% |
| Income Tax | -63.34M | -331.22M | 89.53M | 71M | 167M | -9M | -363M | 120M | 339M | 383M |
| Effective Tax Rate % | -15.1% | 136.77% | 8.15% | 12.14% | 10.8% | -1.53% | -16.85% | 8.04% | 17.57% | 15.85% |
| Net Income | 482.75M▲ 0% | 89.04M▼ 81.6% | 1.01B▲ 1033.7% | 514M▼ 49.1% | 1.38B▲ 168.3% | 597M▼ 56.7% | 2.52B▲ 321.6% | 1.37B▼ 45.5% | 1.59B▲ 15.9% | 2.03B▲ 0% |
| Net Margin % | 7.29% | 1.21% | 12.26% | 5.36% | 12.17% | 4.98% | 17.4% | 8.04% | 9.19% | 11.86% |
| Net Income Growth % | -51.55% | -81.56% | 1033.7% | -49.08% | 168.29% | -56.71% | 321.61% | -45.45% | 15.88% | 139.29% |
| EPS (Diluted) | 11.36▲ 0% | 2.53▼ 77.7% | 24.70▲ 876.3% | 12.78▼ 48.3% | 34.62▲ 170.9% | 15.19▼ 56.1% | 60.24▲ 296.6% | 31.78▼ 47.2% | 37.86▲ 19.1% | 50.49▲ 0% |
| EPS Growth % | -52.03% | -77.73% | 876.28% | -48.26% | 170.89% | -56.12% | 296.58% | -47.24% | 19.13% | 150.87% |
| EPS (Basic) | 11.43 | 2.54 | 24.77 | 12.81 | 34.66 | 15.19 | 60.19 | 31.78 | 37.86 | - |
| Diluted Shares Outstanding | 41.28M | 40.93M | 40.42M | 39.73M | 39.3M | 39M | 41.3M | 42.7M | 41.41M | 40.28M |
Everest Re Group, Ltd. (EG) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 23.59B | 24.79B | 27.32B | 32.71B | 38.19B | 39.97B | 49.4B | 56.34B | 62.51B | 62.34B |
| Asset Growth % | 10.65% | 5.1% | 10.2% | 19.72% | 16.73% | 4.66% | 23.6% | 14.05% | 10.96% | 44.75% |
| Total Investment Assets | 17.99B | 17.78B | 19.94B | 24.66B | 28.23B | 28.47B | 35.7B | 39.98B | 44.11B | 4M |
| Long-Term Investments | 16.36B | 16.19B | 18.18B | 22.65B | 4.75B | 18.04B | 20.56B | 21.09B | 25.91B | 120.31B |
| Short-Term Investments | 4.54B | 4.25B | 5.82B | 8.34B | 23.49B | 10.43B | 15.14B | 18.89B | 18.2B | 2.22B |
| Total Current Assets | 0 | 0 | 0 | 0 | 30.94B | 18.98B | 25.52B | 31.4B | 32.35B | 9.22B |
| Cash & Equivalents | 635.07M | 656.1M | 808.04M | 801.65M | 1.44B | 1.4B | 1.44B | 1.55B | 1.32B | 1.42B |
| Receivables | 3.49B | 4.57B | 4.33B | 4.69B | 5.5B | 6.54B | 8.22B | 10.09B | 12.19B | 40.28B |
| Other Current Assets | -8.95B | -9.81B | -11.41B | -14.24B | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 0 | 0 | 0 | 0 | 872M | 962M | 1.25B | 1.46B | 1.55B | 4.66B |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 872M | 962M | 1.25B | 1.46B | 1.55B | 0 |
| PP&E (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | -16.36B | -16.19B | -18.18B | -22.65B | 1.63B | 1.99B | 2.08B | 2.39B | 2.7B | -43.6B |
| Total Liabilities | 15.22B | 16.89B | 18.19B | 22.99B | 28.05B | 31.52B | 36.2B | 42.47B | 47.05B | 47.05B |
| Total Debt | 1.03B | 1.03B | 1.03B | 3.29B | 5.43B | 5.43B | 5.74B | 5.94B | 3.59B | 3.59B |
| Net Debt | 395.16M | 374.47M | 222.87M | 2.49B | 3.99B | 4.03B | 4.3B | 4.39B | 2.27B | 2.17B |
| Long-Term Debt | 633.39M | 633.61M | 633.83M | 1.91B | 3.09B | 3.08B | 3.39B | 3.59B | 3.59B | 3.59B |
| Short-Term Debt | 396.83M | 396.95M | 397.07M | 1.38B | 2.35B | 2.35B | 2.35B | 2.35B | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 26.47B | 30.16B | 34.41B | 40.4B | 42.52B | 933M |
| Accounts Payable | 218.02M | 218.44M | 291.66M | 294.35M | 450M | 567M | 650M | 701M | 642M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 4.61B | 5.15B | 6.62B | 7.32B | 7.28B | 0 |
| Other Current Liabilities | -656.32M | -669.6M | -722.26M | -1.89B | 19.03B | 22.08B | 24.63B | 29.92B | 34.58B | 933M |
| Deferred Taxes | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | -633.39M | -633.61M | -633.83M | -1.91B | -1.51B | -1.72B | -1.6B | -1.52B | 948M | 46.12B |
| Total Equity | 8.37B▲ 0% | 7.86B▼ 6.1% | 9.13B▲ 16.2% | 9.73B▲ 6.5% | 10.14B▲ 4.3% | 8.44B▼ 16.8% | 13.2B▲ 56.4% | 13.88B▲ 5.1% | 15.46B▲ 11.4% | 15.29B▲ 0% |
| Equity Growth % | 3.64% | -6.08% | 16.18% | 6.5% | 4.25% | -16.76% | 56.4% | 5.11% | 11.42% | 25.72% |
| Shareholders Equity | 8.37B | 7.86B | 9.13B | 9.73B | 10.14B | 8.44B | 13.2B | 13.88B | 15.46B | 15.29B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 9.68B | 9.57B | 10.31B | 10.57B | 11.7B | 12.04B | 14.27B | 15.31B | 16.57B | 17.14B |
| Common Stock | 691K | 692K | 694K | 696K | 1M | 1M | 1M | 1M | 1M | 1M |
| Accumulated OCI | -160.89M | -462.56M | 28.15M | 534.9M | 12M | -2B | -934M | -1.14B | -52M | -462M |
| Return on Equity (ROE) | 5.87% | 1.1% | 11.88% | 5.45% | 13.88% | 6.43% | 23.26% | 10.14% | 10.85% | 13.31% |
| Return on Assets (ROA) | 2.15% | 0.37% | 3.87% | 1.71% | 3.89% | 1.53% | 5.63% | 2.6% | 2.68% | 3.29% |
| Equity / Assets | 35.48% | 31.7% | 33.42% | 29.73% | 26.55% | 21.12% | 26.73% | 24.63% | 24.73% | 24.53% |
| Debt / Equity | 0.12x | 0.13x | 0.11x | 0.34x | 0.54x | 0.64x | 0.43x | 0.43x | 0.23x | 0.23x |
| Book Value per Share | 202.73 | 192.06 | 225.95 | 244.78 | 257.99 | 216.44 | 319.66 | 324.96 | 373.33 | 379.58 |
| Tangible BV per Share | 202.73 | 192.06 | 225.95 | 244.78 | 235.80 | 191.77 | 289.47 | 290.75 | 336.00 | 379.58 |
Everest Re Group, Ltd. (EG) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.16B | 610.07M | 1.85B | 2.87B | 3.83B | 3.69B | 4.55B | 4.96B | 3.4B | 3.4B |
| Operating CF Growth % | -15.97% | -47.53% | 203.57% | 55.18% | 33.37% | -3.6% | 23.22% | 8.87% | -31.37% | -207.72% |
| Operating CF / Revenue % | 17.56% | 8.29% | 22.5% | 29.94% | 33.84% | 30.83% | 31.48% | 29.03% | 19.64% | 19.84% |
| Net Income | 482.75M | 89.04M | 1.01B | 514M | 1.38B | 597M | 2.52B | 1.37B | 1.59B | 2.03B |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -166M | -73M |
| Stock-Based Compensation | 30.3M | 32.37M | 34.02M | 39M | 43M | 45M | 49M | 63M | 61M | 55M |
| Deferred Taxes | 0 | -14.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -56.5M | 241.03M | -72.77M | -95M | 30M | 689M | 332M | -22M | 309M | 129M |
| Working Capital Changes | 706.15M | 247.63M | 881.29M | 2.42B | 2.38B | 2.36B | 1.66B | 3.54B | 1.61B | 712M |
| Cash from Investing | -732.58M | -279.62M | -1.41B | -3.68B | -3.87B | -3.42B | -5.9B | -4.48B | -2.43B | -1.68B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -5.67B | -7.22B | -7.11B | -8.54B | -9.97B | -8.5B | -11.82B | -14.16B | -10.89B | -7.24B |
| Sale/Maturity of Investments | 5.21B | 7.17B | 5.87B | 4.91B | 6.8B | 6.43B | 6.39B | 10.23B | 8.21B | 5.09B |
| Other Investing | -280.46M | -222.39M | -167.04M | -52M | -702M | -1.35B | -476M | -556M | 249M | 469M |
| Cash from Financing | -275.46M | -316.59M | -275.69M | 800M | 674.19M | -359M | 1.41B | -383M | -1.18B | -1.31B |
| Dividends Paid | -207.24M | -216.22M | -234.32M | -249M | -247M | -255M | -288M | -334M | -335M | -330M |
| Share Repurchases | -50M | -75.3M | -24.6M | -200M | -225M | -61M | 0 | -200M | -818M | -953M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 1.45B | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | 0 | 0 | 1000K | 1000K | 0 | 1000K | 1000K | 0 | 0 |
| Other Financing | -18.22M | -25.07M | -16.76M | -40M | -30.81M | -43M | -47M | -49M | -22M | -23M |
| Net Change in Cash | 153.15M▲ 0% | 21.03M▼ 86.3% | 151.94M▲ 622.6% | -6M▼ 103.9% | 639.21M▲ 10753.5% | -43M▼ 106.7% | 39M▲ 190.7% | 112M▲ 187.2% | -231M▼ 306.3% | -152M▲ 0% |
| Exchange Rate Effect | -1.51M | 7.17M | -11.88M | 3M | 639K | 39M | -22M | 16M | -28M | -19M |
| Cash at Beginning | 481.92M | 635.07M | 656.1M | 808.04M | 801.65M | 1.44B | 1.4B | 1.44B | 1.55B | 1.32B |
| Cash at End | 635.07M | 656.1M | 808.04M | 801.65M | 1.44B | 1.4B | 1.44B | 1.55B | 1.32B | 1.42B |
| Free Cash Flow | 1.16B▲ 0% | 610.07M▼ 47.5% | 1.85B▲ 203.6% | 2.87B▲ 55.2% | 3.83B▲ 33.4% | 3.69B▼ 3.6% | 4.55B▲ 23.2% | 4.96B▲ 8.9% | 3.4B▼ 31.4% | 2.86B▲ 0% |
| FCF Growth % | -15.97% | -47.53% | 203.57% | 55.18% | 33.37% | -3.6% | 23.22% | 8.87% | -31.37% | -40.27% |
| FCF Margin % | 17.56% | 8.29% | 22.5% | 29.94% | 33.84% | 30.83% | 31.48% | 29.03% | 19.64% | 16.66% |
| FCF per Share | 28.16 | 14.91 | 45.82 | 72.33 | 97.52 | 94.74 | 110.24 | 116.09 | 82.15 | 82.15 |
Everest Re Group, Ltd. (EG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 93.67% | 103.29% | 86.65% | 93.89% | 86.37% | 95.09% | 85.11% | 91.25% | 88.72% | 85.77% |
| Medical Cost Ratio | 87.98% | 97.4% | 80.51% | 87.77% | 84.75% | 88.68% | 78.67% | 85.53% | 79.48% | 71.52% |
| Return on Equity (ROE) | 5.87% | 1.1% | 11.88% | 5.45% | 13.88% | 6.43% | 23.26% | 10.14% | 10.85% | 13.31% |
| Return on Assets (ROA) | 2.15% | 0.37% | 3.87% | 1.71% | 3.89% | 1.53% | 5.63% | 2.6% | 2.68% | 3.29% |
| Equity / Assets | 35.48% | 31.7% | 33.42% | 29.73% | 26.55% | 21.12% | 26.73% | 24.63% | 24.73% | 24.53% |
| Book Value / Share | 202.73 | 192.06 | 225.95 | 244.78 | 257.99 | 216.44 | 319.66 | 324.96 | 373.33 | 379.58 |
| Debt / Equity | 0.12x | 0.13x | 0.11x | 0.34x | 0.54x | 0.64x | 0.43x | 0.43x | 0.23x | 0.23x |
| Revenue Growth | 14.29% | 11.16% | 11.81% | 16.61% | 18.02% | 5.8% | 20.68% | 18.06% | 1.42% | -0.49% |
Everest Re Group, Ltd. (EG) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Apr 13, 2026·SEC
Mar 23, 2026·SEC
Everest Re Group, Ltd. (EG) stock FAQ — growth, dividends, profitability & financials explained
Everest Re Group, Ltd. (EG) grew revenue by 1.4% over the past year. Growth has been modest.
Yes, Everest Re Group, Ltd. (EG) is profitable, generating $2.03B in net income for fiscal year 2025 (9.2% net margin).
Yes, Everest Re Group, Ltd. (EG) pays a dividend with a yield of 2.30%. This makes it attractive for income-focused investors.
Everest Re Group, Ltd. (EG) has a return on equity (ROE) of 10.8%. This is reasonable for most industries.
Everest Re Group, Ltd. (EG) has a combined ratio of 88.7%. A ratio below 100% indicates underwriting profitability.
Everest Re Group, Ltd. (EG) financial analysis — history, returns, DCA and operating performance tools
Analyst verdict, bull/bear case, risk factors and peer comparison
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates